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It is now widely accepted that cognitive deﬁcits, beyond other psychiatric symptoms (e.g., 
delusion, hallucination, emotional ﬂattening, social withdrawal and apathy), is far most 
relevant to social functional outcome in schizophrenia.  Accordingly, the treatment tar-
get has been shifted to the area, developing new drugs that facilitate cognitive function 
and building up new psychosocial rehabilitation programs that directly approach the 
cognitive deﬁcits.  Despite the desirability to target these deﬁcits, no standard neuro-
psychological test batteries exist for assessing the level of cognitive function.  Mismatch 
negativity (MMN), an auditory event-related potential component, is a measure of preat-
tentive information processing and its amplitude has repeatedly been demonstrated to 
be reduced in schizophrenia.  MMN deﬁcits are a robust feature in chronic schizophre-
nia and indicate abnormalities in automatic context-dependent auditory information 
processing and auditory sensory memory in schizophrenia.  Moreover, the deﬁcits have 
been related to poor social functioning level and social skills acquisition, hypofunction of 
NMDA system, and illness duration, which indicate the validity of accepting MMN as a 
biomarker of the disease.  In this article, we present a summary of the discussions about 
the plausibility of MMN to be used as a neurobiological index for assessing the cognitive 
function and also its predictability of social functional outcome in schizophrenia.
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Cognitive impairment 
as a core feature of schizophrenia
Schizophrenia is a major mental disorder, which 
is clinically diagnosed based on a set of charac-
terized “positive” (e.g., hallucinations, delusions 
and psychomotor excitement), “negative” (e.g., 
emotional ﬂattening, social withdrawal and apa-
thy) and “cognitive” (disturbances in memory, at-
tention and problem solving) symptoms.  Among 
these symptoms, cognitive impairment has been 
noticed as the core feature of schizophrenia since 
Bleuler described “schizophrenias” almost one 
hundred years ago.  Attention has been increas-
ingly focused on cognition since Green (1996) 
clearly demonstrated that the cognitive impair-
ment was the strongest factor that should affect 
the social and functional outcome.  Green (1996) 
divided the functional outcome into three sections 
according to type of outcome measure.  The ﬁrst 
section represents community (social and occupa-
tional) functioning and the second, assessment of 
social problem solving and the third, ability to ac-
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quire psychosocial skills from their psychosocial 
rehabilitation programs.  Among various cogni-
tive domains, verbal memory was associated with 
all types of functional outcome, vigilance was 
related to social problem solving and executive 
functioning was related to community function-
ing.  The major features of the cognitive impair-
ment of schizophrenia are summarized in Table 1 
(Meltzer et al., 1999).
 The conventional antipsychotic drugs such 
as chlorpromazine and haloperidol, referred to 
as dopamine antagonists, were certainly effec-
tive against “positive” symptoms but generally 
ineffective against “negative” and “cognitive” 
symptoms.  Meanwhile, many researchers demon-
strated that the new drugs, referred to as serotonin 
dopamine antagonist and multi-acting receptor-
targeted antipsychotics, or atypical antipsychotic 
drugs, showed a favorable effect on cognition 
using neuropsychological test batteries, however, 
whether the new drugs could affect the social 
functional outcome was not at all clear.  One of 
the reasons for the negative results could be that 
the effect size of the drugs (0.5–1.5 SD) on cogni-
tive function was not ample enough to reach the 
normal level (the difference between patients with 
schizophrenia and normal controls being 1.0–3.0 
SD) and thus, was unable to affect the social func-
tional outcome.  There has been a national project 
sponsored by National Institute of Mental Health 
named MATRICS (Measurement and Treatment 
Research to Improve Cognition in Schizophrenia) 
in the United States, which aims to develop novel 
drugs for the treatment of cognitive impairments 
in schizophrenia.  Also, in the ﬁeld of psychoso-
cial treatment, “cognitive remediation therapy”, 
which refers to the procedures used to directly 
improve cognitive function, has attracted growing 
interest of individuals engaged in psychiatric ser-
vices.  
The assessment of 
cognitive impairment in schizophrenia
The assessment of cognitive impairment in 
schizophrenia has owed much to neuropsycho-
logical test batteries.  As noted above, the ﬁndings 
are in agreement in that the new drugs are effec-
tive on cognitive function in general, however, the 
speciﬁcity of the effect of each drug has not been 
clariﬁed.  Although the pharmacological proﬁles 
of these drugs were clearly different between each 
other, the cognitive proﬁles that were affected by 
these drugs were not as clearly distinct as expect-
ed.  
 The inconsistent and nonspecific findings 
are, at least in part, caused by the relatively weak 
validity of neuropsychological tests.  First, as 
prompt response is required in many tests, the 
performance level is affected not only by the 
stimulus processing speed but also by the motor 
speed, which makes the interpretation of the re-
sults difﬁcult.  Moreover, as the assessment using 
neuropsychological tests depend solely on be-
havioral indices, they are subject to motivational 
Table 1.  Major features of cognitive impairment of schizophrenia
a) All domains of cognition, including attention, executive function, secondary (storage) memory, working memory, 
and semantic memory, may be affected.
b) The pattern of deﬁcits may vary widely among individuals with schizophrenia.
c) The mean deﬁcit in these domains may be 1–3 standard deviations below normal, although about 15% of patients 
with schizophrenia test within the normal range in all domains.
d) For most patients, impairment is only slowly progressive after the ﬁrst episode of psychosis.
e) Some components of the deﬁcit are present during childhood and early adolescence but usually in mild form.
f) Deﬁcits in speciﬁc types of cognition are of key importance for work and social function in schizophrenia, more 
so even than positive or negative symptoms.
Reprinted from Cognition, schizophrenia, and the atypical antipsyochotic drugs, by Meltzer et al., Proceedings of the National Academy 
of Sciences of the United States of America, 1999, volume 96, pages 13591–13593.  Copyright© 1993–2005 by The National Academy of 
Sciences of the United States of America, all rights reserved.
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inﬂuences, which should also be contaminated in 
the assessment of cognitive function.  Finally, the 
construct validity of neuropsychological tests has 
not been well established.  For instance, “continu-
ous performance test (CPT)” is usually intended 
to measure vigilance as well as sustained atten-
tion over time (Cornblatt et al., 1989).  During the 
task, subjects are presented with single letters or 
numbers in a short duration that appear at a rapid 
ﬁxed rate.  The subjects are required to respond 
with a button press each time a predesigned target 
stimulus appears.  It can be assumed that other 
psychometric properties such as automatic stimu-
lus perceptual capacity, independent from either 
vigilance or attention, may contribute to the CPT 
performance.  Also, in our previous study, we in-
vestigated the relationship between the scores in 
Tower of Hanoi test  and Wisconsin Card Sorting 
Test, which are both well known as measures of 
executive functioning, however, we found no rela-
tionship between them in schizophrenia patients 
(Katoh et al., 2003).  
 In the MATRICS project, researchers are 
now focusing on several neuroimaging and elec-
trophysiology biomarkers to gain reliable and 
sensitive indices associated with the brain activity 
underlying more speciﬁc cognitive domains.  As 
is well known, electrophysiological methods are 
superior in terms of time sensitivity but limited in 
spatial resolution as compared with neuroimaging 
methods.  Magnetoencephalogram measurements 
hold high quality of spatial information as well 
as time sensitivity, whereas they still have limita-
tion in that they can only detect the current in the 
tangential direction to the scalp.  Scalp current 
density analysis (SCD) is another method used for 
improving spatial resolution, which was calculat-
ed by taking the Laplacian of the scalp potential 
surface generated by spherical spline interpola-
tion (Nunez, 1981; Perrin et al., 1989).  As SCD 
computation is equivalent to applying a high-pass 
spatial filter to the potential fields, the maxima 
and minima of their distribution are clearer than 
those of the potential ﬁelds.  Moreover, since the 
sensitivity of the SCD mappings decreases with 
the depth of the generator in the brain, they may 
allow the splitting of the overlapped components 
arising from the cortex that show distinct sink/
source patterns.  Formally, it is based on simpli-
fications of Poisson’s equation relating the field 
potential at any point in the conductive medium 
to their underlying current generators, so that a 
local generator of an extracellular negativity (cur-
rent sink) corresponds to local neuronal depo-
larization, while a local generator of a positivity 
(current source) corresponds to hyperpolariza-
tion.  Although the anatomical and physiological 
organization of putative generator regions must be 
carefully evaluated before attributing physiologi-
cal correlates to SCD components, it can be rea-
sonably assumed that SCD is useful in elucidating 
the cortical activities associated with the compo-
nent speciﬁed.  
 Concerning the advantage of electrophysi-
ological methods such as event-related potentials 
(ERP) in temporal resolution, they allow the early 
stages of sensory and perceptual information pro-
cessing, as well as later cognitive and premotor 
processes to be distinguished precisely in time. 
Moreover, overall processing speed can be as-
sessed without contamination by motor dysfunc-
tion.  Disadvantages include the fact that ERP 
components have not been identified across the 
full array of candidate cognitive domains under 
consideration and are relatively limited in measur-
ing sustained processing.
 Up to date candidate components for the as-
sessment of cognitive impairment in schizophre-
nia may come from sensory and early cognitive 
processing.  For instance, mismatch negativity 
(MMN, see Fig. 1), an early auditory ERP elic-
ited by deviant stimuli even though the subjects 
ignored the series of stimuli, has some attractive 
features such as good test-retest reliability (Kath-
mann et al., 1999; Kujala et al., 2001) and has 
been shown to correlate with functional outcome 
(Light and Braff, 2005).  MMN is an ERP com-
ponent that is generated when a stimulus violates 
the invariance or regularity of the previous series 
of standard stimuli.  MMN has been considered 
to be independent of subjects’ attention, however, 
some studies have reported that under exceptional 
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circumstances attention can indirectly modulate 
MMN (Trejo et al., 1995; Sussman et al., 1998). 
MMN is best observed in the difference wave-
form subtracting the ERP responses to standard 
stimuli from those to deviant stimuli and usually 
peaks within 100 and 240 ms after the deviant 
stimulus is presented.  It’s maximum negativity 
is seen over fronto-central region and it reverses 
its polarity near the mastoid in a nose-referenced 
montage.  Larger differences between the stan-
dards and deviants and lower probability of the 
deviants are associated with larger MMN ampli-
tude.  In the most simple paradigm an infrequent 
stimulus that differs in any physical characteristic 
such as frequency, duration, intensity or location 
is presented among repeatedly presented standard 
stimuli, however, violations of more abstract regu-
larities not directly related to physical character-
istics of the stimuli (e.g., repetition of a tone in 
series of alternating tones) also generate MMN. 
Thus, MMN generation depends on the context 
in which a speciﬁc stimulus is presented.  MMN 
is therefore considered an index of preattentive 
auditory processing, reﬂecting automatic context-
dependent information processing and auditory 
sensory memory.  This early component has the 
possible advantage of being relatively automatic 
and less prone to “noise” from top-down cognitive 
inﬂuences or practice effects, thereby potentially 
being more direct probes of the functional integ-
rity of underlying neural structures.  MMN can 
be contrasted with later components such as the 
P300, the error-related negativity, or slow waves 
such as the contingent negative variation, which 
are thought to reﬂect some of the critical cogni-
tive disturbances in schizophrenia but are subject 
to top-down inﬂuences such as task instructions 
or strategy differences.  Furthermore, numer-
ous studies have identified the neural substrates 
generating MMN in primary and secondary audi-
tory cortices (Hari et al., 1984; Scherg et al., 1989; 
Javitt et al., 1994; Alho, 1995; Levänen et al., 1996; 
Celsis et al., 1999; Opitz et al., 1999, 2002; Downar 
et al., 2001; Jemel et al., 2002; Müller et al., 2002; 
Liebenthal et al., 2003; Sabri et al., 2004) and in 
frontal cortex (Giard et al., 1990; Levänen et al., 
1996; Rinne et al., 2000; Yago et al., 2001; Downar 
et al., 2001, 2002; Jemel et al., 2002; Müller et al., 
2002; Opitz et al., 2002; Liebenthal et al., 2003; 
Sabri et al., 2004); however, those generating later 
Fig. 1.  MMN waveform (A) and amplitude/SCD topographies 
(B, C).
A: The upper figure represents ERP waveforms elicited by 
deviant (bold line) and standard (dashed line) stimuli. The 
lower ﬁgure shows difference waveforms subtracting ERPs 
to standard stimuli from those to deviant stimuli. 
B: The upper ﬁgure represents the MMN peak amplitude (144 
ms) topography projecting the 3-D locations onto the 2-D 
plane.  The lower ﬁgures represent the amplitude topogra-
phy projected on the reconstructed 3-D brain image.
C: The same ﬁgures as (B) using SCD instead of amplitude 
data.
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components have not been so clearly identiﬁed.
 Näätänen and Michie (1979) suggested a 
functional dissociation between the two genera-
tors, with the temporal generator associated with 
establishment of memory traces and comparison 
with incoming stimulus attributes and the frontal 
generator related to involuntary triggering of at-
tention invoked by the detected change.  Although 
a few studies have provided some support for this 
view (Müller et al., 2002; Sabri et al., 2004, 2006; 
Shalgi et al., 2007), direct evidence for the sug-
gested division of function between the superior 
temporal and frontal cortices is still lacking.
MMN in schizophrenia
MMN deﬁcits, mostly amplitude reduction, are a 
robust feature in chronic schizophrenia and indi-
cate abnormality in preattentive context-depen-
dent auditory information processing and sensory 
memory in these patients.  Overall, the mean ef-
fect size on MMN amplitude reduction was 0.99 
(95% confidence intervals: 0.79–1.2) (Umbricht 
and Krljes, 2005).
 Since the ﬁrst report of abnormal MMN in 
schizophrenia by Shelley et al. (1991), there have 
been numerous studies on MMN in schizophrenia 
using various stimulus conditions (e.g., type of 
deviants, probability/degree of deviants) and sub-
jects’ populations (e.g., sex, age, duration of ill-
ness).  Generally, in terms of the probability and 
degree of deviant stimulus, the lower the probabil-
ity and the stronger the deviance, the larger the 
amplitude of MMN becomes.  Most frequently 
used types of deviance were those differing in 
tone frequency and tone duration.  MMN elic-
ited by the deviant stimuli differing in duration 
appeared more impaired in schizophrenia than 
those differing in tone frequency (Michie et al., 
2000; Javitt et al., 2000b; Umbricht et al., 2003), 
however, the meta-analysis reported by Umbricht 
and Krljes (2005) demonstrated that the differ-
ence between types failed to reach significance 
level.  Moreover, they suggested that the frequen-
cy MMN deﬁcits associated with illness duration 
and thus, may index ongoing neuropathological 
changes in the auditory cortex in schizophrenia. 
In line with the view, Yamasue et al. (2004) dem-
onstrated that the magnetic global ﬁeld power of 
mismatch response to change in phonemes in the 
left hemisphere was signiﬁcantly correlated with 
left planum temporale gray matter volume in pa-
tients with schizophrenia. The finding suggests 
that structural abnormalities of the planum tem-
porale may underlie the abnormalities of MMN 
generation in schizophrenia.
 
MMN deﬁcits associated with 
suppressed NMDA action in schizophrenia
The evidence from genetic, brain imaging, clinical 
and pharmacologic studies suggests that schizo-
phrenia is a heterogeneous group of disorders 
(Kirkpatrick et al., 2001; Harrison and Weinberger, 
2004).  All current antipsychotics exert their ef-
fects primarily by blocking the D2 dopamine re-
ceptors.  However, with the exception of clozapine 
in a subgroup of patients, the conventional and 
even new drugs leave most patients substantially 
disabled due to negative symptoms and cogni-
tive impairments.  There is now strong reason to 
suspect abnormalities in N-methyl-d-aspartate 
(NMDA) receptor function may contribute to 
these symptoms that are resistant to antipsychotic 
medications.
 Since their introduction nearly 50 years ago, 
the dissociative anaesthetics such as ketamine and 
phencyclidine (PCP) were known to cause a psy-
chotic syndrome that was difﬁcult to distinguish 
from schizophrenia (Itil et al., 1967).  Based upon 
emerging pharmacology of the NMDA receptors, 
Javitt and Zukin (1991) proposed that the psy-
chomimetic effects of PCP were due to blockade 
of the NMDA receptors.  Since then, numerous 
studies demonstrated that negative and cognitive 
symptoms as well as neurophysiological signs of 
schizophrenia were sensitive to the psychomi-
metic effects of ketamine even in low dose level 
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(Krystal et al., 1994; Radant et al., 1998; Adler et 
al., 1999; Newcomer et al., 1999; Umbricht et al., 
2000; Lahti et al., 2001).
 Javitt et al. (1996) used a combination of 
intracortical recording and pharmacological mi-
cromanipulations in monkeys and demonstrated 
that both competitive and noncompetitive NMDA 
antagonists blocked the generation of MMN. 
These ﬁndings suggest that, on a neurophysiologi-
cal level, MMN represents selective current ﬂow 
through open, unblocked NMDA channels.  Also 
in humans, Umbricht et al. (2000) reported 27% 
and 21% reduction of MMN amplitude caused 
by ketamine administration in pitch and duration 
deviance conditions, respectively (Fig. 2).  More-
over, the authors demonstrated that ketamine in-
duced performace deﬁcits in the AX-CPT (CPT 
in which subjects were required to press a button 
whenever the letter “A” was followed by the let-
ter “X” while all other sequences were to be ig-
nored) characterized by speciﬁc increases of BX 
errors (erroneous response to “X” not preceded 
by “A”), reﬂecting a failure to form and use tran-
sient memory traces of task relevant information. 
Thus, NMDA receptor dysfunction was thought 
to underly deficits in transient memory at both 
automatic and controlled levels of information 
processing in schizophrenia.
MMN deﬁcits and 
cognitive impairments in schizophrenia
It cannot be emphasized too strongly that the 
main goal of psychiatric treatment is not only to 
relieve the symptom levels or even improve cog-
nitive impairments per se, but also to ameliorate 
the patients’ sufferings presumably by reinforcing 
their social skills and facilitating their levels of 
QOL.  Therefore, whether MMN represents the 
domain of cognitive function closely related to so-
cial functional outcome is obviously an essential 
point from clinical point of view.
 MMN deﬁcits in schizophrenia do not seem 
to be related consistently to symptom domains, al-
though a few studies found signiﬁcant correlations 
with negative symptom levels (Catts et al., 1995; 
Hirayasu et al., 1998; Javitt et al., 2000a; Kasai et 
al., 2002).  Given the strong evidence from stud-
ies by Näätänen and their colleagues (Näätänen 
et al., 1992) that MMN indexes auditory sensory 
memory and automatic context-dependent infor-
mation processing, it is surprising that not much 
attention has been given to possible relationships 
of deﬁcits in MMN to deﬁcits in higher cognitive 
functions.  There are only few studies reporting 
such relationships, suggesting that MMN deﬁcits 
are particularly pronounced in patients with mem-
ory impairment (Baldeweg et al., 2004; Umbricht 
et al., 2004; Kawakubo et al., 2006).  Baldeweg 
et al. (2004) used a new stimulation protocol 
with continuously changing (“roving”) standard 
stimuli in order to measure the effect of standard 
Fig. 2.  Effects of ketamine administration on MMN in 
the pitch (A) and duration (B) deviance condition (n = 
20).
 The gray lines represent the MMN wave during the 
baseline recording before ketamine administration; the 
black line, during infusion of ketamine; and the dark area, 
the difference between the two curves (i.e., the reduction 
of MMN during ketamine administration) (Reprinted with 
permission from Ketamine-induced deﬁcits in auditory and visual 
context-dependent processing in healthy volunerrs:  Implicatio-
ans for models of cognitive deﬁcits in schizophrenia, by Umbricht 
et al., Archives of General Psychiatry, volume 57, pages 1139–
1147.  Copyright© 2000 by the American Medical Association. 
All rights reserved).
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repetitions on MMN (memory trace effect), which 
was robustly correlated with the degree of neu-
ropsychological memory impairment in general 
rather than static measures of ERP magnitude. 
Kawakubo et al. (2006) measured MMN elicited 
by change in tone duration and phoneme duration 
in 23 schizophrenia patients in addition to evalu-
ation for auditory verbal memory and executive 
function.  They found that MMN under the pho-
neme duration condition was signiﬁcantly associ-
ated with scores for verbal memory but not with 
executive function whereas tone duration MMN 
was not correlated with indices of either verbal 
memory or executive function.  Considering that 
verbal memory is thought to be one of the main 
targets in treatment, due to the large effect size of 
it’s impairment in schizophrenia patients as com-
pared with the performance in healthy individuals 
and also it’s strong relationship with various types 
of functional outcome (Green et al., 1996), the 
ﬁndings suggest that further assessment of MMN 
in response to speech sound may be of greater im-
portance than MMN in response to simple tones.
MMN deﬁcits 
related to functional outcome?
Let us now focus on our main concern, that is, 
the relationship between MMN deﬁcits and social 
functional outcome.  Can measurement of MMN 
be of use in assessing the community functioning 
level and/or ability of social problem solving and/
or ability to acquire psychosocial skills from their 
psychosocial rehabilitation programs?  Do MMN 
deficits predict poor social functional outcome 
longitudinally?  Not enough answers have been 
obtained yet.
 Light and Braff (2005) first reported that 
MMN deficits were associated with poor social 
functional status.  In their study greater MMN 
deficits were associated with lower Global As-
Fig. 3.  MMN is signiﬁcantly associated with clinician-rated global assessments of functioning in schizophrenia pa-
tients at frontocentral electrodes (  = 0.01).  The different shades represent the degree of association between GAF Scale 
scores and MMN across individual electrode site using Spearman nonparametric rank correlations. Signiﬁcant associa-
tions were present at the following electrodes:  F3, F4, F7, F8, FC1, FC2, FC5, FC6, Fz, C3, C4, CP1, CP2, and Cz.  The 
panel on the right shows the position of electrode F3 and the correlation of MMN to GAF Scale score (r = –0.65, P < 0.001) 
(Reprinted with permission from Mismatch negativity deﬁcits are associated with poor functioning in schizophrenia patients, by Light 
and Braff, Archives of General Psychiatry, volume 62, pages 127–136.  Copyright© 2005 by the American Medical Association.  All 
rights reserved).
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sessment of Functioning (GAF) Scale ratings and 
also with lower level of independence in commu-
nity living situation (Fig. 3).  Kawakubo et al. (in 
press) investigated the relationship between MMN 
and the degree of social skills acquisition follow-
ing 3 months training in schizophrenia patients to 
see whether MMN can predict social skills acqui-
sition longitudinally.  They found that larger SCD 
values for right frontal/temporal MMN elicited 
by across phoneme change (deviant stimulus; /o/, 
standard stimulus; /a/) at baseline were signifi-
cantly associated with the degree of improvement 
in total social skills scores assessed by a struc-
tured role play test.  It should be noted that SCD 
computation improves spatial resolution level and 
Giard et al. (1990) successfully differentiated the 
current activities arising from the temporal gen-
erator and those from the frontal generator involv-
ing mainly the right hemisphere by using SCD. 
The ﬁndings that the social skills acquisition was 
associated with the right frontal/temporal SCD 
component but not with the bilateral temporal 
SCD components may indicate that the social 
skills acquisition was more strongly related to 
involuntary triggering process of attention rather 
than auditory sensory memory function.  More-
over, tone duration MMN along with phoneme 
duration MMN showed no relationship with so-
cial skills acquisition.  As in the study mentioned 
above done by the same research group, the im-
pairment in early automatic processing of speech 
sound may be relevant to schizophrenia patients’ 
social functional outcome.
Conclusions and future directions
Deficits in MMN generation are a robust fea-
ture in schizophrenia.  The neural substrates and 
neurotransmitter functions subserving MMN is 
becoming clear.  MMN deficits are present in 
clinically unaffected family members (Jessen et 
al., 2001; Michie et al., 2002), which suggest it 
may be a potentially useful endophenotype to al-
low the investigation of potential abnormalities 
in genes coding for the various subunits of the 
NMDA receptor in a subgroup of patients deﬁned 
by MMN deﬁcits.  Moreover, as a preattentional 
cognitive index, MMN may accurately character-
ize the integrity of sensory network dysfunction 
free of attentional or motivational artifacts, which 
is an additional advantage of this component to be 
used as a biomarker. 
 It remains controversial, however, in terms 
of which domain of higher cognitive functions 
MMN deficits are associated with.  Moreover, 
we have only limited information about the re-
lationship between MMN and social functional 
outcome in schizophrenia.  Taking into consider-
ation the MMN in response to speech sound was 
associated with verbal memory and also with so-
cial skills acquisition, further studies using more 
sophisticated paradigms, such as those assessing 
language functions might be promising. 
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